| |
| Dissanayake
SK, Thompson JA, Bosch JJ, Clements VK, Chen PW, Ksander
BR, Ostrand-Rosenberg
S. |
| |
Activation of tumor-specific CD4(+) T lymphocytes
by major histocompatibility complex class II tumor cell
vaccines: a novel cell-based immunotherapy. Cancer Res.
2004 64:1867-1874. [PubMed
listing][PDF]. |
|
|